{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Integrated Proteins Ltd
Integrated Proteins Ltd is Rated Strong Sell
Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Are Integrated Proteins Ltd latest results good or bad?
Integrated Proteins Ltd's latest results are concerning, showing a complete halt in operations with net sales of ₹0.00 crore and a net loss of ₹0.02 crores in Q3 FY26, reflecting severe operational challenges and a significant decline in investor confidence.
Integrated Proteins Q3 FY26: Operations Grind to a Halt as Revenue Collapses
Integrated Proteins Limited, a micro-cap edible oil processor with a market capitalisation of ₹55.00 crores, reported a complete operational shutdown in Q3 FY26, with net sales plummeting to zero from ₹4.20 crores in the previous quarter. The company, which processes oilseeds including soyabean, mustard, and groundnut, swung to a net loss of ₹0.02 crores compared to a profit of ₹0.05 crores in Q2 FY26, marking a concerning reversal for the Jamnagar-based firm.
When is the next results date for Integrated Proteins Ltd?
The next results date for Integrated Proteins Ltd is 12 February 2026.
Integrated Proteins Ltd is Rated Strong Sell
Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Integrated Proteins Ltd is Rated Strong Sell
Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 January 2026, providing investors with the latest insights into the stock’s performance and outlook.
Integrated Proteins Ltd is Rated Strong Sell
Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Integrated Proteins Ltd is Rated Strong Sell
Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Integrated Proteins Ltd is Rated Strong Sell
Integrated Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Why is Integ. Proteins falling/rising?
On 12-Dec, Integrated Proteins Ltd witnessed a notable decline in its share price, closing at ₹34.30 with a loss of 4.99%. This drop reflects a continuation of the stock's underperformance relative to both its sector and broader market indices, driven by a combination of weak long-term fundamentals and subdued investor participation.
Integ. Proteins Sees Revision in Market Evaluation Amidst Challenging Fundamentals
Integ. Proteins, a microcap player in the edible oil sector, has undergone a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. This adjustment highlights ongoing challenges in the company’s financial performance and market positioning, underscoring the need for investors to carefully consider the evolving landscape.
Integrated Proteins Faces Intense Selling Pressure Amidst Consecutive Losses
Integrated Proteins Ltd has encountered significant selling pressure on 4 December 2025, with the stock opening sharply lower and trading exclusively at its intraday low. The absence of buyers and persistent downward momentum highlight distress selling signals, marking a challenging phase for the edible oil company amid broader market fluctuations.
Is Integ. Proteins overvalued or undervalued?
As of November 27, 2025, Integ. Proteins is considered undervalued with an attractive investment appeal, reflected in its favorable PE ratio of 42.60 and EV to EBITDA of 14.06, despite a year-to-date return of -49.13%, while showing a strong three-year return of 97.78%.
Integrated Proteins Faces Intense Selling Pressure Amidst Prolonged Downtrend
Integrated Proteins Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the edible oil company as it continues to face consecutive losses and a significant downtrend over the past year.
Is Integ. Proteins overvalued or undervalued?
As of November 10, 2025, Integ. Proteins is considered undervalued with an attractive valuation grade, a PE ratio of 42.60, and strong recent performance, significantly outperforming peers like Manorama Industries and CIAN Agro.
How has been the historical performance of Integ. Proteins?
Integ. Proteins has shown significant growth, with net sales reaching 21.50 Cr in March 2025, up from 0.24 Cr in March 2024. The company also reported increased operating profit, profit before tax, and profit after tax, alongside a rise in earnings per share to 0.71.
Are Integ. Proteins latest results good or bad?
Integrated Proteins' latest Q2 FY26 results show a recovery with net sales of ₹4.20 crores and a small profit of ₹0.05 crores, but significant challenges remain due to erratic revenue patterns and thin profitability, raising concerns about long-term viability.
Integrated Proteins Q2 FY26: Micro-Cap Edible Oil Processor Shows Signs of Life After Years of Dormancy
Integrated Proteins Limited, a Jamnagar-based edible oil processor, reported a net profit of ₹0.05 crores for Q2 FY26, marking a tentative return to operational activity after years of minimal business. The micro-cap company, with a market capitalisation of just ₹13.00 crores, recorded net sales of ₹4.20 crores during the quarter—a dramatic contrast to the near-zero revenues witnessed in preceding quarters. Despite this operational revival, the stock remains deeply troubled, down 21.92% over the past year and trading at ₹38.25 as of November 7, 2025, following a 5.00% single-day gain.
Integrated Proteins Ltd Faces Significant Selling Pressure with 25.64% Yearly Loss and 51.55% Decline YTD
Integrated Proteins Ltd is experiencing notable selling pressure, continuing a trend of losses. Despite a recent monthly increase, the stock has faced significant declines over three months and year-to-date. The erratic trading pattern and broader sector decline are contributing to negative market sentiment surrounding the company.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
